NCT02052531View on ClinicalTrials.gov

Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Skin Pruritus
Interventions
DRUG

PAC-14028

Participants received topical PAC-14028 cream 0.3 or 1% twice daily for 4 weeks

OTHER

Vehicle

Participants received topical Vehicle twice daily for 4 weeks

Trial Locations (1)

110-744

Kyu-Han Kim, Seoul

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02052531 - Evaluation of the Antipruritic Effect of PAC-14028 Cream in Skin Pruritus | Biotech Hunter | Biotech Hunter